Skip Nav Destination
You do not currently have access to this content.
SOX17 Mediates Immune Evasion During Early Colon Cancer Progression Available to Purchase
March 8, 2024
Major Finding: Early stage colorectal adenomas and cancers upregulate SOX17 to escape immune surveillance.
Concept: SOX17 suppresses sensitivity to IFNγ signaling and inhibits immunogenicity and antigen presentation.
Impact: These data suggest that restoring IFNγ responses may strengthen immune-mediated tumor clearance.
DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-039
Article Type:
Research Watch
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Advertisement